Caxton Associates (UK)’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,978
Closed -$226K 849
2025
Q1
$226K Buy
+5,978
New +$226K 0.01% 682